What You Need to Know About Monoclonal Antibodies for COVID-19
Monoclonal antibody (MAB) therapy has shown great promise for people who have tested positive for COVID-19, by managing symptoms and reducing the risk of getting sicker. In particular, MAB therapy, has shown significant benefits in reducing the progression of the illness in the long-term care population.
Now that long-term care pharmacies can dispense MABs in skilled nursing facilities, the impact is expected to be dramatic.
Fill out this form to download a free tip sheet that can be shared with residents, staff, and families to better understand this life-saving treatment.